Back to trial detailsIntake questionnaire
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Applying to Multiple Sclerosis Center, Swedish Neuroscience Institute · Seattle, Washington
Answer a few short questions to share with the research team.
0 of 4 answered